Milestone Pharmaceuticals...

NASDAQ: MIST · Real-Time Price · USD
1.70
0.02 (1.19%)
At close: Aug 15, 2025, 3:59 PM
1.67
-1.47%
After-hours: Aug 15, 2025, 07:57 PM EDT

Milestone Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a -868K n/a n/a 1M 3.5M 1.5M n/a n/a 15M n/a 15M n/a
Cost of Revenue
27K 567K n/a 26K 28K 532K 24K 24K n/a 406K 9.83M 24K 23K 292K 24K 9.43M 23K
Gross Profit
-27K n/a n/a -26K -28K -1.4M -24K -24K 1M 3.09M -8.33M -24K -23K 14.71M -24K 5.57M -23K
Operating Income
-20.62M -12.35M -9.62M -9.66M -10.54M -13.87M -15.36M -16.44M -15.5M -13.76M -15.03M -16.81M -14.05M -16.92M -14.27M 712K -12.59M
Interest Income
697K 904K 1.08M 1.19M 994K 1.05M 1.12M 1.21M 585K 582K 474K 158K 40K 34K 48K 58K 80K
Pretax Income
-20.85M -12.43M -9.44M -9.36M -10.42M -13.69M -15.08M -16.04M -14.95M -13.18M -14.56M -16.65M -14.01M -16.88M -14.22M 770K -12.51M
Net Income
-20.76M -12.36M -9.44M -9.36M -10.35M -13.61M -15.08M -16.04M -14.95M 18.26M -14.08M -16.49M -13.97M -16.88M -14.22M 770K -12.51M
Selling & General & Admin
15.52M 8.41M 5.65M 6.82M 6.81M 8.35M 8.64M 7.81M 6.25M 6.68M 6.7M 6.15M 5.28M 6M 4.54M 4.86M 4M
Research & Development
5.07M 3.94M 3.96M 2.88M 3.71M 5.43M 6.72M 8.62M 10.26M 10.58M 9.83M 10.66M 8.77M 10.92M 9.73M 9.43M 8.6M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a 48.92M 2.67M n/a n/a 45.67M n/a 1.84M n/a
Operating Expenses
20.59M 11.85M 9.62M 9.66M 10.52M 13.34M 15.36M 16.44M 16.5M 17.26M 16.53M 16.81M 14.05M 16.92M 14.27M 14.29M 12.59M
Interest Expense
935K 919K 903K 887K 872K 857K 841K 820K 33K n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a 4.41M 1.91M 1.8M 2.88M 4.98M 4.41M 3.37M 2.36M 2.56M 2.67M 2.23M 1.64M 2.21M 1.58M 1.84M 1.37M
Cost & Expenses
20.62M 12.35M 9.62M 9.66M 10.54M 13.87M 15.36M 16.44M 16.5M 17.26M 16.53M 16.81M 14.05M 16.92M 14.27M 14.29M 12.59M
Income Tax Expense
-93K -65K n/a n/a -68K -74K n/a n/a n/a -31.43M -474K -158K -40K 34K n/a n/a -91K
Shares Outstanding (Basic)
66.29M 62.21M 66.19M 66.17M 50.16M 33.48M 42.97M 42.94M 42.85M 42.78M 42.49M 42.28M 42.24M 42.18M 42.19M 41.67M 41.26M
Shares Outstanding (Diluted)
66.29M 62.21M 66.19M 66.17M 50.16M 33.48M 42.97M 42.94M 42.85M 42.78M 42.49M 42.28M 42.24M 42.18M 42.19M 44.53M 41.26M
EPS (Basic)
-0.31 -0.2 -0.14 -0.14 -0.21 -0.41 -0.35 -0.37 -0.35 0.43 -0.33 -0.39 -0.33 -0.4 -0.34 0.02 -0.3
EPS (Diluted)
-0.31 -0.2 -0.14 -0.14 -0.21 -0.41 -0.35 -0.37 -0.35 0.43 -0.33 -0.39 -0.33 -0.4 -0.34 0.02 -0.3
EBITDA
-19.89M -10.94M -9.62M -8.52M -9.52M -12.3M -14.3M -15.27M -14.9M -13.74M -14.53M -16.78M -14.02M -16.89M -14.25M 735K -12.57M
EBIT
-19.92M -11.44M -8.54M -8.54M -9.48M -12.83M -14.33M -15.29M -14.92M -13.76M -14.56M -16.77M -14.05M -16.92M -14.27M 712K -12.59M
Depreciation & Amortization
27K 567K 25K 26K 28K 532K 24K 24K 18K 406K 27K 24K 23K 292K 24K 23K 23K